Large randomized trial "recalibrates expectations," experts say ...

Use of high-flow oxygen was associated with less of a need for mechanical ventilation and a shorter time to recovery compared with conventional oxygen therapy in patients with severe COVID-19, a ...

Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic ...

Please provide your email address to receive an email when new articles are posted on . Researchers split the total cohort into five groups. All groups minus immunocompromised patients with hypoxemia ...

Increased respiratory patient illness, COVID-19, and product recalls have created a critical need for ventilators in the United States, said David Shockley, Movair’s CEO, in a recent company press ...

IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., a technology leader in the respiratory industry, announced today that it has received FDA clearance to market its Bonhawa High Flow Oxygen Therapy ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with severe disease were significantly less likely to require mechanical ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to the Bonhawa High Flow Oxygen Therapy system for patients with respiratory ...

Risk of secondary hematologic malignancies in patients with ovarian cancer treated with PARP inhibitors: A combined meta-analysis of seven phase III randomized controlled trials. This is an ASCO ...

Randomized trial shows no difference from sham control ...